Form D · Biotechnology
Clarametyx Biosciences, Inc.
Columbus, OH · CIK 0002008752
Offering snapshot reported Jan 19, 2024 · SEC filing
- Reported sold
- $27.5M Offering amount: $33.1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 5, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 19, 2024 | Initial | $27,524,145 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-502987
Source: Form D, filed Jan 19, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Baumel | Director |
| Chuck Bramlage | Director |
| Larry Edwards | Director |
| Wayne Embree | Director |
| Peter G. Kleinhenz | Director |
| Michael Layman | Director |
| David Richards | Executive |
| Michael Triplett Ii | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1275 Kinnear Road
Columbus, OH, 43212
Columbus, OH, 43212